Windlas Biotech Limited (NSE:WINDLAS)

Windlas Biotech Revenue

Windlas Biotech had revenue of 2.10B INR in the quarter ending June 30, 2025, with 19.95% growth. This brings the company's revenue in the last twelve months to 7.95B, up 20.19% year-over-year. In the fiscal year ending March 31, 2025, Windlas Biotech had annual revenue of 7.60B with 20.43% growth.

• Revenue (ttm): 7.95B
• Revenue Growth: +20.19%
• P/S Ratio: 2.63
• Revenue / Employee: n/a
• Employees: 1,154
• Market Cap: 20.87B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	7.60B	1.29B	20.43%
Mar 31, 2024	6.31B	1.18B	22.97%
Mar 31, 2023	5.13B	471.53M	10.12%
Mar 31, 2022	4.66B	383.28M	8.96%
Mar 31, 2021	4.28B	987.50M	30.03%